Keveyis

Product manufactured by Strongbridge Us Inc.

Application Nr Approved Date Route Status External Links
NDA011366 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Keveyis Is Indicated For The Treatment Of Primary Hyperkalemic Periodic Paralysis, Primary Hypokalemic Periodic Paralysis, And Related Variants. Keveyis Is An Oral Carbonic Anhydrase Inhibitor Indicated For The Treatment Of Primary Hyperkalemic Periodic Paralysis, Primary Hypokalemic Periodic Paralysis, And Related Variants ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dichlorphenamide DICHLORPHENAMIDE ZINC896918

Comments